Latest Articles

29. 01. 2021

List of reimbursed medicinal products valid as of 1.2.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

25. 01. 2021

Data Mailbox Set-up for Foreign Entities

The Ministry of Interior sets up data mailboxes upon request also for natural persons-entrepreneurs and legal entities-businesses incorporated in a foreign country.

 

13. 01. 2021

Requirements for Electronic Signature of Clinical Trial Applications Submitted In Fully Electronic Format

The electronic signature must meet the requirements of Regulation No 910/2014 on electronic identification and trust services for electronic transactions in the internal...

 

31. 12. 2020

List of reimbursed medicinal products valid as of 1.1.2021

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

30. 11. 2020

List of reimbursed medicinal products valid as of 1.12.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

13. 11. 2020

IMP with GMO for the treatment of COVID in CT 12.11.2020

Information on documentation to be submitted for clinical trials on medicinal products for the treatment of COVID-19, 7.11.2020, updated 12.11.2020

 

04. 11. 2020

Important Information for Applicants for Clinical Trials through the Voluntary Harmonisation Procedure - Brexit and Christmas Break 2020/2021

The State Institute for Drug Control hereby informs the sponsors of clinical trials that  VHP Christmas Break 2020 will be from 22 December 2020 to 6 January 2021.